State-of-the-art expertiseState-of-the-art expertise
Life sciencesLife sciences

A booming industry in Québec City's metropolitan region

Key figures

150 companies
5,400 jobs
$1.4 CDN billion estimated in sales
85 centres, research chairs, clusters and institutes

Data compiled for the Québec City metropolitan region

With a state-of-the-art expertise in biopharmaceuticals, diagnostics, natural health products (cosmeceuticals and nutraceuticals), medical technologies and information technologies related to health, the Québec City metropolitan region is ideally positioned for a growing market. The global market of pharmaceutical products alone should double before 2020 to reach CDN $1.8 billion (PricewaterhouseCoopers 2010)-and the life sciences industry in the Québec City metropolitan region is set to reap the benefits.

Health research in Québec City CMA is :

  • Over 60 Canada research chairs and partner chairs, including 2 Canada excellence research chairs
  • 20 research centres and institutes recognized by Université Laval
  • 10 university faculties with teaching and research programs
  • More than 600 research professors, many with international reputations
  • $357 million in grants and contracts in the last 3 years
  • Almost 200 research and innovation agreements with international partnerships, for a total value of over $17 million in 2014-2015
  • 1.7 million people served by the health network

Leaders with state-of-the-art expertise

The Québec City metropolitan region is distinguished by leaders and innovative companies with state-of-the-art expertise:

A region in the vanguard of health research

The Québec City metropolitan area stands out for its ability to harness science and know-how in health research. At its center, the Université Laval, one of Canada's ten leading research universities, owes much of its success to the knowledge and influence of internationally recognized faculty members. Discoveries by Québec City region health and social services research teams help shape a society committed to sustainable health and well-being.

Main research centres

  • CHU de Québec Research Center
    The leading French-language health research centre in North America is a motor for economic development in and of itself, and a cornerstone of the region's development into a health sciences powerhouse. Outstandingresearch teams and state-of-the-art infrastructure have earned the centre an enviable national and international reputation.
  • Quebec Heart and Lung Institute Research Centre
    The institute is a world leader in the fields of cardiology, respirology and obesity surgery, three areas identified as priorities due to the economic and societal impact of diseases associated with them. The alignment between the institute's research and clinical missions makes it a unique facility, with patients being the main beneficiaries.
  • CERVO Brain Research Centre
    One of the leading neuroscience and mental health research facilites in Canada, it is home to some 60 research teams that study the main causes of brain diseases. The centre develops innovative new approaches, including tools for early detection of neurological and mental illnesses, as well as a multitude of new optics/photonics technologies.
  • Center for Interdisciplinary Research in Rehabilitation and Social Integration
    The activities of the centre focus on personal (impairments and disabilities) and environmental (obstacles and facilitators) that influence the social participation of people living with physical disabilities.
  • Infectious Disease Research Center
    1st in Canada, 5th worldwide
  • Institute of Nutrition and Functional Foods
    The largest concentration of professors-researchers in food sciences and technologies in Canada

Major healthcare and social service institutions

Investing in a favourable business environment

With a thriving life sciences industry, the Québec City metropolitan region benefits from recent, ongoing and future investments:

  • Expansion and renovation of Hôtel-Dieu de Québec Hospital - CDN $635 million
  • Upgrade and modernization of facilities, GSK - CDN $300 million
  • Building of a vaccine plant, Medicago - CDN $254 million
  • New R&D center for molecular diagnostic products, BD GeneOhm - CDN $60 million
  • Otto Bock / Victhom Human Bionics - CDN $30 million
  • Obesity research laboratories, CRIUCPQ - CDN $28 million

Québec City is no 1 in North America for business operating costs for cities in its category. It is 16.1% less expensive to set up shop and do business in the region than in the average American cities. The cost-benefit ratio is even greater for clinical trials (34.7%) and biomedical research (33.1%).
- Competitive Alternatives 2016, KPMG and Conjoncture 2016, Léger

According to KPMG's 2010 Competitive Alternatives report, operating costs in the Québec City metropolitan region are lower than the average for North American cities in clinical trials (27%), biomedical R&D (20%) and manufacturing pharmaceuticals (6 %)-making it #1 in Canada and the United States.

Life sciences - Fact sheet

For more information

Life sciences - Fact sheet

Vaccines, infectiology, development of new medications, clinical research, diagnostic tools,  telehealth, medical equipment, clinical mobility, cosmeceuticals, nutraceuticals,  functional foods, cardiology, pneumology, oncology, tissue engineering

Portrait of these industries in the Quebec City Region. Produced by Québec International.

pdf_icon_32 Download the brochure

 
 
Share this page

You can share this page on :

Contacts

Jean-MichelGarroLife Sciences

More details

Newsletter

Subscribe to our newsletter for interesting news and information.

Print this page